Wednesday, February 10, 2010, 4:07pm SGT - The Singapore stock market closes in 53 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Bristol-Myers Squibb Co. (BMY)

At 5:00AM SGT: 24.25 USD   0.00 (0.00%)  
 MORE ON BMY 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BRISTOL-MYERS SQUIBB (NYSE:BMY) Delayed quote dataEdit
Last Trade:24.25 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:24.25
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:24.99
Day's Range:N/A - N/A
52wk Range:17.23 - 26.62
Volume:0
Avg Vol (3m):26,002,100
Market Cap:48.04B
P/E (ttm):12.55
EPS (ttm):1.93
Div & Yield:1.25 (5.15%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add BMY to Portfolio   Download Data

 HEADLINES 
•Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets
at Barrons.com (Wed 9:20am)
•Researchers find sex-specific lung cancer genes
at Reuters (Wed 8:34am)
•How Much Should Cancer Drugs Cost?
at The Wall Street Journal Online (Wed 5:05am)
•Make Thousands From Millions
at Motley Fool (Wed 2:20am)
•UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Tue 8:57am)
•UK says Novartis, Bristol cancer drugs too costly
at Reuters (Tue 8:01am)
•Monday Options Recap: Volatility Eases
at Seeking Alpha (Tue 4:55am)
•Correction is Healthy - and a Buying Opportunity: Strategist
at CNBC (Tue 12:55am)
•AMRI reports $19M net loss in 4Q
at bizjournals.com (Mon, Feb 8)
•UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Mon, Feb 8)
•How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
•Bristol-Myers Squibb to freeze salaries in 2010
AP (Sat, Feb 6)
•Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times (Sat, Feb 6)
•Why Pharma's Patent Cliff Is Good News for Pharmacies
at The Wall Street Journal Online (Fri, Feb 5)
•[$$] Cost Cutting Boosts Profits
at The Wall Street Journal Online (Fri, Feb 5)
More Headlines for BMY...
 ANALYST 
EPS Est (next year) (Dec-09) :1.78
EPS Est (in 2 years) (Dec-10) :2.21
Avg Rec (current)*:2.6
PEG Ratio:5.21
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and nutritional products worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices